FDA Adverse Event Injury Summary report: N

GALAXY SYSTEM

MDR report key: 23897335 · Received December 26, 2025

Report

Report Number
3021325287-2025-00070
Event Type
Injury
Date Received
December 26, 2025
Date of Event
September 17, 2024
Report Date
December 26, 2025
Manufacturer
NOAH MEDICAL CORP
Product Code
EOQ
PMA / PMN Number
K223144
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

SYSTEM AND BRONCHOSCOPE MANUFACTURING RECORDS WERE REVIEWED AND FOUND NO ISSUES ASSOCIATED WITH THIS CASE. MANUFACTURING RECORDS CONFIRMED THAT THE SCOPE PASSED FINAL QA/QC TESTING PRIOR TO RELEASE. VIDEO REVIEW IDENTIFIED NO USE ERRORS OR SYSTEM MALFUNCTIONS. BIOPSIES WERE PERFORMED UNDER LIVE FLUOROSCOPY, AND NEITHER THE TOOL NOR THE SCOPE EXCEEDED AF BOUNDARIES. THE PHYSICIAN DID NOT ATTRIBUTE THE BLEEDING TO THE GALAXY SYSTEM, NOTING THAT IT APPEARED TO ORIGINATE FROM THE FORCEPS BIOPSY. BASED ON ALL AVAILABLE INFORMATION, THE EVENT IS MOST CONSISTENT WITH THE KNOWN INHERENT RISKS OF BRONCHOSCOPY AND TRANSBRONCHIAL BIOPSY.

Description of Event or Problem · 0

BLEEDING WAS OBSERVED IN THE RIGHT UPPER LOBE (RUL) FOLLOWING A FORCEPS BIOPSY AND PROGRESSIVELY INCREASED AFTER ADDITIONAL FORCEPS BIOPSIES. THE GALAXY SCOPE WAS LEFT IN PLACE AND TRANEXAMIC ACID WAS ADMINISTERED LOCALLY THROUGH THE WORKING CHANNEL. THE GALAXY BRONCHOSCOPE WAS THEN REMOVED, AND A THERAPEUTIC SCOPE WAS INSERTED THROUGH THE ENDOTRACHEAL TUBE (ETT) TO VISUALIZE, CLEAN THE AIRWAY, AND ASSESS FOR CONTINUED BLEEDING. THE PATIENT WAS STABILIZED AND ADMITTED FOR 4 DAYS. NO MALFUNCTIONS WERE REPORTED. ATTEMPTS TO GATHER PATIENT DEMOGRAPHICS WERE UNSUCCESSFUL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2344868 GALAXY SYSTEM GALAXY SYSTEM BRONCHOSCOPE GALB-001 EOQ NOAH MEDICAL CORP GALB-001 2024071801

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention| H